Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
13 January 2010 and was completed on 8 February 2010.
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: This study was performed according to the protocol with two amendments, with the exception of the minor deviations none of which were considered to prejudice the validity of this study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
oxo[(oxoalumanyl)oxy]alumane; silanedione
EC Number:
604-314-4
Cas Number:
142844-00-6
Molecular formula:
amorphous glass Si(n)O(3n+1) polymeric anions bonded to Zr and Al(3+)
IUPAC Name:
oxo[(oxoalumanyl)oxy]alumane; silanedione
Details on test material:
Name of test material( as cited in study report): RCF Covance
Substance type: Inorganic
- Physical state: solid
- Analytical purity: 100%
- Impurities (identity and concentrations):trace
- Purity test date: 14.12.09
- Lot/batch No.: BG-10-X99-2982
- Expiration date of the lot/batch: 31.1.2020
- Stability under test conditions: stable
- Storage condition of test material: sealed container room temp

Method

Target gene:
Histidine
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
not applicable
Species / strain / cell type:
S. typhimurium TA 102
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
without
Metabolic activation system:
material is completely inorganic so none is needed
Test concentrations with justification for top dose:
see table1 in other information on methods section, range finder and mutation experiments were carried out
Vehicle / solvent:
- Vehicle(s)) used:; 1% methylcellulose ( MC);
- Justification for choice of vehicle:test article is insoluble in all possible vehicles compatible with the assay system. The test article was therefore tested as a suspension in 1% MC. Ultrasonication was used to ensure homogeneity of the stock suspension and the formulations were stirred continuously (using a magnetic stirrer) prior to their addition to the test system.
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
2-nitrofluorene
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
mitomycin C
Details on test system and experimental conditions:
METHOD OF APPLICATION: in suspension; Ultrasonication was used to aid homogenity of the stock suspension and the formulation was stirred continually (using magnetic stirrer) prior to addition to the test system

DURATION
- Preincubation period: 10 hours
- Exposure duration: 2-3 days

Metabolic activation is in appropriate for totally inorganic materials of this type
Evaluation criteria:
For valid data, the test article was considered to be mutagenic if:
1. Dunnett's test gave a significant response (p ≤ 0.01) which was concentration
related
2. the positive trend/effects described above were reproducible.
The test article was considered as positive in this assay if all of the above criteria were met.
The test article was considered as negative in this assay if none of the above criteria were met.
Test article was considered as positive in this assay if all of the above criteria were met
The test article was considered as negative in this assay if none of the above criteria were met
Statistics:
Dunnett's test was used to compare the counts at each concentration with the control

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 102
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not determined
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not determined
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not determined
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 98
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not determined
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Species / strain:
S. typhimurium TA 100
Metabolic activation:
without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not determined
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: material is an insoluble inorganic solid

RANGE-FINDING/SCREENING STUDIES:
Initial toxicity Range-Finder Experiment was carried out in strain TA100 only, using final concentrations of AES Covance at 1.6, 8, 40, 200, 1000 and 5000 μg/plate, plus negative (vehicle) and positive controls. Following these treatments, no evidence of toxicity was observed, as would normally be indicated by a thinning of the background bacterial lawn and/or a marked reduction in revertant numbers.

COMPARISON WITH HISTORICAL CONTROL DATA:
Control counts were compared with the accepted normal ranges for the test laboratory for numbers of spontaneous revertants on vehicle control plates and numbers of induced revertants on positive control plates. Data were considered acceptable if the mean vehicle control counts fell within the historical 99% confidence intervals for group means and/or each vehicle control plate count fell within the historical 99% reference ranges, and the positive control plate counts were comparable with the historical 99% reference ranges. The ranges that are quoted are based on a large volume of historical control data accumulated from experiments where the correct strain and assay functioning are considered to have been confirmed. Data for our laboratory are consistent with ranges of spontaneous revertants per plate considered acceptable elsewhere.

ADDITIONAL INFORMATION ON CYTOTOXICITY:
Initial toxicity Range-Finder Experiment was carried out in strain TA100 only, using final concentrations of RCF Covance at 1.6, 8, 40, 200, 1000 and 5000 μg/plate, plus negative (vehicle) and positive controls. Following these treatments, no evidence of toxicity was observed, as would normally be indicated by a thinning of the background bacterial lawn and/or a marked reduction in revertant numbers.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Raw plate counts and calculated mutagenicity data Experiment 1

 

Table 3: RCF Covance Raw plate counts and calculated mutagenicity data - Experiment 1, TA98 –S-9

Compound

Concentration

µg/plate

Revertant numbers/plate

Mean

N

Fold increase

Standard deviation

Dunnett’s t-value

significance

1% MC

 

22,40,26,27,34

29.8

5

 

7.2

 

 

RCF Covance

1.6

25,25,30

26.7

3

0.9

2.9

-0.57

NS

RCF Covance

8

34,43,35

37.3

3

1.3

4.9

1.44

NS

RCF Covance

40

25,25,29

27.3

3

0.9

2.3

-0.64

NS

RCF Covance

200

31P,13P,25P

23

3

0.8

9.2

-1.50

NS

RCF Covance

1000

26 P,23P,26 P

25

3

0.8

1.7

-0.92

NS

RCF Covance

5000

14 P,26P,34P

24.7

3

0.8

10.1

-1.15

NS

2NF

5

 

814.3

3

27.3

36.9

 

 

Dunnett’s t-test significance values

NS Not significant

* p ≤ 0.05

** p ≤ 0.01

Positive controls

2NF 2-Nitrofluorene

NaN3 Sodium azide

AAC 9-Aminoacridine

MMC Mitomycin C

Table Postfixes

B Bubbles or split in agar

M Plate counted manually

P Particulate test article observed (by eye)

Table 4: RCF Covance Raw plate counts and calculated mutagenicity data - Experiment 1, TA100 -S-9

Compound

Concentration

µg/plate

Revertant numbers/plate

Mean

N

Fold increase

Standard deviation

Dunnett’s t-value

significance

1% MC

 

79,101,117,103,70

94.0

5

 

19.1

 

 

RCF Covance

1.6

114,88,88

96.7

3

1.0

15.0

0.34

NS

RCF Covance

8

110, 103, 104

105.7

3

1.1

3.8

1.33

NS

RCF Covance

40

100, 89, 101

96.7

3

1.0

6.7

0.37

NS

RCF Covance

200

103 P, 100 P, 104 P

102.3

3

1.1

2.1

0.99

NS

RCF Covance

1000

94 P, 74 P, 96 P

88.0

3

0.9

12.2

-0.62

NS

RCF Covance

5000

105 P, 91 P, 101 P

99.0

3

1.1

7.2

0.62

NS

NaN3

2

1134, 1081, 1084

1099.7

3

11.7

29.8

 

 

Table 5 :RCF CovanceRaw plate counts and calculated mutagenicity data - Experiment 1, TA1535 -S-9

Compound

Concentration (mg/plate)

Revertant numbers/plate

Mean

N

Fold Increase

Standard Deviation

Dunnett’s t‑value

Significance

 

 

 

 

 

 

 

 

 

1% MC

 

16, 16, 18, 16, 10

15.2

5

 

3.0

 

 

RCF Covance

1.6

17, 16, 17

16.7

3

1.1

0.6

0.46

NS

RCF Covance

8

17, 36, 27

26.7

3

1.8

9.5

2.82

*

RCF Covance

40

8, 14, 16

12.7

3

0.8

4.2

-0.82

NS

RCF Covance

200

17 P, 13 P, 13 P

14.3

3

0.9

2.3

-0.24

NS

RCF Covance

1000

9 P, 21 P, 17 P

15.7

3

1.0

6.1

0.05

NS

RCF Covance

5000

13 P, 23 P, 13 P

16.3

3

1.1

5.8

0.28

NS

NaN3

2

568, 604, 607

593.0

3

39.0

21.7

 

 

 

 

 

 

 

 

 

 

 

Table 6: RCF CovanceRaw plate counts and calculated mutagenicity data - Experiment 1, TA1537 -S-9

Compound

Concentration (mg/plate)

Revertant numbers/plate

Mean

N

Fold Increase

Standard Deviation

Dunnett’s t‑value

Significance

 

 

 

 

 

 

 

 

 

1% MC

 

6, 10, 12, 14, 4

9.2

5

 

4.1

 

 

RCF Covance

1.6

5, 12, 21

12.7

3

1.4

8.0

0.73

NS

RCF Covance

8

18, 12, 6

12.0

3

1.3

6.0

0.66

NS

RCF Covance

40

19, 3, 19

13.7

3

1.5

9.2

0.82

NS

RCF Covance

200

17 P, 14 P, 12 P

14.3

3

1.6

2.5

1.28

NS

RCF Covance

1000

13 P, 10 P, 10 P

11.0

3

1.2

1.7

0.54

NS

RCF Covance

5000

12 P M B, 5 P, 8 P

8.3

3

0.9

3.5

-0.19

NS

AAC

50

43, 77, 65

61.7

3

6.7

17.2

 

 

 

 

 

 

 

 

 

 

 

Table 7 : RCF CovanceRaw plate counts and calculated mutagenicity data - Experiment 1, TA102 -S-9

Compound

Concentration (mg/plate)

Revertant numbers/plate

Mean

N

Fold Increase

Standard Deviation

Dunnett’s t‑value

Significance

 

 

 

 

 

 

 

 

 

1% MC

 

273, 289, 302, 261, 251

275.2

5

 

20.6

 

 

RCF Covance

1.6

240, 289, 315

281.3

3

1.0

38.1

0.39

NS

RCF Covance

8

303, 296, 321

306.7

3

1.1

12.9

2.19

NS

RCF Covance

40

302, 298, 321

307.0

3

1.1

12.3

2.21

NS

RCF Covance

200

283 P, 308 P, 305 P

298.7

3

1.1

13.7

1.65

NS

RCF Covance

1000

295 P, 309 P, 305 P

303.0

3

1.1

7.2

1.95

NS

RCF Covance

5000

286 P, 295 P, 269 P

283.3

3

1.0

13.2

0.59

NS

MMC

0.2

927, 922, 867

905.3

3

3.3

33.3

 

 

 

 

 

 

 

 

 

 

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative without metabolic activation

It was concluded that RCF Covance did not induce mutation in
five histidine-requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of
Salmonella typhimurium when tested under the conditions of this study. These
conditions included treatments at concentrations up to 5000 μg/plate, in the absence
of any exogenous metabolic activation system
Executive summary:

It was concluded that RCF Covance did not induce mutation in five histidine‑requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of Salmonella typhimurium when tested under the conditions of this study. These conditions included treatments at concentrations up to 5000 mg/plate, in the absence of any exogenous metabolic activation system